It is a pharma private limited company based in Madurai, Tamil Nadu, India, established in 2013.
2013 | Madurai, Tamil Nadu, India | ActiveSm Drugs Private Limited, a active private limited company, was established on 19 December 2013 in Madurai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51101TN2013PTC094223. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Shanmugasundari (Director), Kanthimathinathan Palani Kandasamy (Director). Past directors included Rajapalayam Venkatachalam Shridaran, Krishnamoorthy Vidya. It holds ₹5.43 M open charges and ₹2.50 M settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Sm Drugs Private Limited, 218, First Floor North Marrat Street, Naicker New Street, Madurai, Tamil Nadu, 625001.
U51101TN2013PTC094223
094223
19 December 2013
₹3.00 M
₹0.40 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sm Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shanmugasundari | Director | 24 Nov 2015 | Current |
| Kanthimathinathan Palani Kandasamy | Director | 24 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Dec 2015 | Past |
| Pramod Abcsdd | Director | 26 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sm Drugs Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 57.78% increase. The company also saw a substantial fall in profitability, with a 94.63% decrease in profit. The company's net worth moved up by a moderate rise of 0.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Sm Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,429,000.00
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2019 | The South Indian Bank Limited | ₹5.43 M | Open |
| 01 Aug 2017 | Others | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sm Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sm Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sm Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 01 Aug 2017 via Charge ID 100114488 with Others was fully satisfied on 20 Apr 2021. was documented.
Progress on A charge with The South Indian Bank Limited of Rs. 5.43 M registered on 15 May 2019 with Charge ID 100266684 was modified on 20 Jun 2020. was documented.
Progress on A charge with The South Indian Bank Limited amounted to Rs. 5.43 M with Charge ID 100266684 was registered on 15 May 2019. was documented.
The activity Sm Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
The activity Sm Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Chennai. was completed.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100114488 was registered on 01 Aug 2017. was documented.
The CIN of Sm Drugs Private Limited is U51101TN2013PTC094223.
Sm Drugs Private Limited is headquartered at Sm Drugs Private Limited, 218, First Floor North Marrat Street, Naicker New Street, Madurai, Tamil Nadu, 625001.
Sm Drugs Private Limited was incorporated on 19 December 2013.
The current directors of Sm Drugs Private Limited are
The primary industry of Sm Drugs Private Limited is Pharma.
Sm Drugs Private Limited is unlisted.
The authorized capital of Sm Drugs Private Limited is ₹3.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Sm Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX